Correlation Between Puma Biotechnology and Estrella Immunopharma
Can any of the company-specific risk be diversified away by investing in both Puma Biotechnology and Estrella Immunopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Puma Biotechnology and Estrella Immunopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Puma Biotechnology and Estrella Immunopharma, you can compare the effects of market volatilities on Puma Biotechnology and Estrella Immunopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Puma Biotechnology with a short position of Estrella Immunopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Puma Biotechnology and Estrella Immunopharma.
Diversification Opportunities for Puma Biotechnology and Estrella Immunopharma
0.45 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Puma and Estrella is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Puma Biotechnology and Estrella Immunopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Estrella Immunopharma and Puma Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Puma Biotechnology are associated (or correlated) with Estrella Immunopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Estrella Immunopharma has no effect on the direction of Puma Biotechnology i.e., Puma Biotechnology and Estrella Immunopharma go up and down completely randomly.
Pair Corralation between Puma Biotechnology and Estrella Immunopharma
Given the investment horizon of 90 days Puma Biotechnology is expected to generate 10.86 times more return on investment than Estrella Immunopharma. However, Puma Biotechnology is 10.86 times more volatile than Estrella Immunopharma. It trades about 0.02 of its potential returns per unit of risk. Estrella Immunopharma is currently generating about 0.0 per unit of risk. If you would invest 297.00 in Puma Biotechnology on September 14, 2024 and sell it today you would lose (5.00) from holding Puma Biotechnology or give up 1.68% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 28.57% |
| Values | Daily Returns |
Puma Biotechnology vs. Estrella Immunopharma
Performance |
| Timeline |
| Puma Biotechnology |
| Estrella Immunopharma |
Puma Biotechnology and Estrella Immunopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Puma Biotechnology and Estrella Immunopharma
The main advantage of trading using opposite Puma Biotechnology and Estrella Immunopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Puma Biotechnology position performs unexpectedly, Estrella Immunopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Estrella Immunopharma will offset losses from the drop in Estrella Immunopharma's long position.| Puma Biotechnology vs. Ultragenyx | Puma Biotechnology vs. Crinetics Pharmaceuticals | Puma Biotechnology vs. Arvinas | Puma Biotechnology vs. Revolution Medicines |
| Estrella Immunopharma vs. Puma Biotechnology | Estrella Immunopharma vs. Iovance Biotherapeutics | Estrella Immunopharma vs. Day One Biopharmaceuticals | Estrella Immunopharma vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |